nach oben

Drug Safety

Erschienen in:

01.10.2011 | Meeting Report

Communication in Drug Safety

A Report from an Interactive Debate Held at the 10th Annual Meeting of the International Society of Pharmacovigilance (ISoP), 2010

verfasst von: Dr Priya Bahri, Peter G. M. Mol, Hélène Théophile, I. Ralph Edwards, Bruce P. J. Hugman

Erschienen in: Drug Safety | Ausgabe 10/2011

Einloggen, um Zugang zu erhalten

Excerpt

Public communication on safety concerns over medicines and advice on how to prevent medicineinduced patient harm is a decisive challenge for the overall success of those responsible for pharmacovigilance. …

Titel: Communication in Drug Safety
A Report from an Interactive Debate Held at the 10th Annual Meeting of the International Society of Pharmacovigilance (ISoP), 2010
verfasst von: Dr Priya Bahri
Peter G. M. Mol
Hélène Théophile
I. Ralph Edwards
Bruce P. J. Hugman
Publikationsdatum: 01.10.2011
Verlag: Springer International Publishing
Erschienen in: Drug Safety / Ausgabe 10/2011
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI: https://doi.org/10.2165/11594430-000000000-00000

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Communication in Drug Safety

A Report from an Interactive Debate Held at the 10th Annual Meeting of the International Society of Pharmacovigilance (ISoP), 2010

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2011

Is the Large Simple Trial Design Used for Comparative, Post-Approval Safety Research?

International Society of Pharmacovigilance Abstracts 11th ISoP Annual Meeting ‘Next Stop: Istanbul — Bridging the Continents!’ Istanbul, Turkey 26–28 October 2011

Drug-Induced Taste and Smell Alterations

Drug-Induced Photosensitivity

Effect of Pre-Medication on Early Adverse Reactions Following Antivenom Use in Snakebite

Fluoroquinolone-Associated Myasthenia Gravis Exacerbation